Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct

Recruiting

Phase 2 Results N/A

Summary of Purpose

This study aims to determine the efficacy of intravenous transplantation of autologous bone marrow-derived mesenchymal stem cells in patients with acute middle cerebral artery infarct.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 March 2015.

1 Mar 2012 25 Oct 2011 1 Dec 2015 1 Mar 2016 1 Mar 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Norlinah Mohamed Ibrahim, MD